OncoResponse

OncoResponse develops a pipeline of immunomodulatory antibodies derived from elite responders’ immune systems. Its Lead program targets the M2-like TAMs in the tumor microenvironment.


Website

www.oncoresponseinc.com

Partner

Wende Hutton

Investment

Series A